Part,  Chapter, Paragraph

 1   II,     5.  5.  3|               the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~Andlin-Sobocki
 2   II,     5.  5.  3|               disorders in Europe. Eur J Neurol 12 Suppl 1:74-77.~Andrews
 3   II,     5.  5.  3|             prevalence, and prognosis. J Neurol Neurosurg Psychiatry 58:
 4   II,     5.  5.  3|                 systematic review. Eur J Neurol 12:245-253.~Fraser RT, Clemmons
 5   II,     5.  5.  3|                 with epilepsyCurr Opin Neurol 17:141-146.~Kotsopoulos
 6   II,     5.  5.  3|        prospectively over 11-14 years. J Neurol Neurosurg Psychiatry 71:
 7   II,     5.  5.  3|               associated health usage. J Neurol Neurosurg Psychiatry 69:
 8   II,     5.  5.  3|              sudden death in epilepsy. J Neurol Neurosurg Psychiatry 60:
 9   II,     5.  5.  3|                prospective study. Lancet Neurol 4:627-634.~Osservatorio
10   II,     5.  5.  3|                 drivers with epilepsy. J Neurol Neurosurg Psychiatry 60:
11   II,     5.  5.  3|             Mures County, Romania. Rom J Neurol Psychiatry 32:115-122.~Bencsik
12   II,     5.  5.  3|            Csongrád County, Hungary. Eur Neurol 46:206-209.~Benedikz J,
13   II,     5.  5.  3|            Móstoles, central Spain. Acta Neurol Scand 98:238-242.~Berkowicz
14   II,     5.  5.  3|                and genetic factors. Acta Neurol Scand 91(Suppl 161):71-76.~
15   II,     5.  5.  3|                  a 25-year period. Eur J Neurol 8:463-469.~Confavreux C,
16   II,     5.  5.  3|                for multiple sclerosis. J Neurol Neurosurg Psychiatr 55:671–
17   II,     5.  5.  3|         sclerosis registersEDMUS. Ann Neurol 36(suppl):S136–S139.~Confavreux
18   II,     5.  5.  3|                and incidence study. Acta Neurol Scand 109:378-384.~De Sã
19   II,     5.  5.  3|                 of Santarem, Portugal. J Neurol 253:914-918.~Dean G, Elian
20   II,     5.  5.  3|              Malta in 1999: an update. J Neurol Neurosurg Psychiatry 73;
21   II,     5.  5.  3|             trends, and prospects. Eur J Neurol 11:511–520~EUROPA. The EU
22   II,     5.  5.  3|                  McDonald criteria. Acta Neurol Scand 109:385-389.~Firnhaber
23   II,     5.  5.  3|                gradients really exist? J Neurol 246:1033–1040.~Ford HL,
24   II,     5.  5.  3|                Leeds Health Authority. J Neurol Neurosurg Psychiatry 64:
25   II,     5.  5.  3|           multiple sclerosis in Leeds. J Neurol 249:260-265.~Fox-Rushby
26   II,     5.  5.  3|              prevalence in Ferrara. Arch Neurol 53:793-798.~Gross K, Kokk
27   II,     5.  5.  3|                Fennoscandian focus. Acta Neurol Scand 88:241-246.~Grytten
28   II,     5.  5.  3|                indigeneous population. J Neurol 247;129-133.~Haffenden S,
29   II,     5.  5.  3|          Multiple Sclerosis Society. Eur Neurol. 2006;56(2):78-105~Horakova
30   II,     5.  5.  3|                 Sclerosis Registry. Acta Neurol Scand 78:369380.~Koch-Henriksen
31   II,     5.  5.  3|                 multiple sclerosis. Arch Neurol 45:435-437.~Kurtzke JF (
32   II,     5.  5.  3|                  Northern Ireland, UK. J Neurol Neurosurg Psychiatry 64:
33   II,     5.  5.  3|                  of genetic diversity. J Neurol Neurosurg Psychiatry 75:
34   II,     5.  5.  3|          Multiple sclerosis in Cyprus. J Neurol Sci 103:29-36.~Milanov I,
35   II,     5.  5.  3|             province of Teruel, Spain. J Neurol 244:182-185.~Mor u T, eaManceau
36   II,     5.  5.  3|          population-based ascertainment. Neurol Res 22:156-159.~MSTCG (Multiple
37   II,     5.  5.  3|              practice and research. Acta Neurol Scand 183(Suppl):37-40.~
38   II,     5.  5.  3|                  Croatia and Slovenia. J Neurol Sci 247:169-172.~Piperidou
39   II,     5.  5.  3|           province of Evros, Greece. Eur Neurol 49:8-12.~Poser CM, Paty
40   II,     5.  5.  3|                 and incidence 1993-1995. Neurol Neurochir Pol 33:575-585.~
41   II,     5.  5.  3|               true increasing risk. Acta Neurol Scand 103:20-26~Pugliatti
42   II,     5.  5.  3|               sclerosis in Europe. Eur J Neurol 13: 700722.~Pugliatti M,
43   II,     5.  5.  3|              districts of East Anglia. J Neurol Neurosurg Psychiatry 59:
44   II,     5.  5.  3|                genetic predisposition. J Neurol Neurosurg Psychiatry 64:
45   II,     5.  5.  3|                 critical overview. Can J Neurol Sci 20:17-29.~Sarasoja T,
46   II,     5.  5.  3|         comparison during 30 years. Acta Neurol Scand 110: 331336.~Sobocki
47   II,     5.  5.  3|               sclerosis in Finland. Acta Neurol Scand 103:153-158.~Sumelahti
48   II,     5.  5.  3|           progressive disease courses. J Neurol Neurosurg Psychiatry 74:
49   II,     5.  5.  3|                 in northern Sweden. Acta Neurol Scand 103:214-218.~Sundström
50   II,     5.  5.  3|             County in northern Sweden. J Neurol Neurosurg Psychiatry 74:
51   II,     5.  5.  3|             County in northern Sweden. J Neurol Neurosurg Psychiatry 75;
52   II,     5.  5.  3|            Valladolid, northern Spain. J Neurol 246:170-174.~Totaro R, Marini
53   II,     5.  5.  3|               district, central Italy. J Neurol Neurosurg Psychiat 68:349-
54   II,     5.  5.  3|           sclerosis in French farmers. J Neurol Neurosurg Psychiatry 78:
55   II,     5.  5.  3|               the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~Baldereschi
56   II,     5.  5.  3|                in Parkinson's disease. J Neurol Sci. 262:37-44.~Errea JM,
57   II,     5.  5.  3|               for Parkinson’s disease. J Neurol Sci 217(2):169-174.~Granieri
58   II,     5.  5.  3|                  1967 through 1987. Arch Neurol 48(8):854-857.~Hely MA,
59   II,     5.  5.  3|                  and post-levodopa eras. Neurol Clin 10(2):331-339.~Horstink
60   II,     5.  5.  3|               Parkinson’s disease. Eur J Neurol 13(11):1170-1185.~Hughes
61   II,     5.  5.  3|                 disease in Europe. Eur J Neurol 12 Suppl 1:68-73.~Logroscino
62   II,     5.  5.  3| Steele-Richardson-Olszewski syndrome). J Neurol Neurosurg Psych 76(4):498-
63   II,     5.  5.  3|         parkinsonian patients. Psychiatr Neurol Med Psychol:385-394.~Spottke
64   II,     5.  5.  3|          Evidence from twin studies. Adv Neurol 91:133-142.~Twelves D, Perkins
65   II,     9.  1.  1|                 registers. Dev Med Child Neurol 2000;42(12):816-24.~ ~Stephenson
66   II,     9.  3.  2|                 registers. Dev Med Child Neurol 2000;42(12):816-24.~ ~Temmerman
67   IV,    13.  9    |               the brain in Europe. Eur J Neurol 12 Suppl 1:1-27.~EPC (Economic